{"cluster": 62, "subcluster": 0, "abstract_summ": "In the present narrative, we review SARS-CoV-2 virology, clinical features, pathophysiology, and animal models with a specific focus on the antiviral and adjunctive therapies currently being tested or that require testing in animal models and randomized clinical trials.\u2022 COVID-19, an alarming pandemic outbreak of 2020.Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for an ongoing human pandemic (COVID-19).We also discuss potential therapeutic targets, either host virus based, that could be used to tackle the COVID-19 outbreak.Through previous lessons learned from SARS-CoV-1 and MERS-CoV studies, scientific groups worldwide have rapidly expanded the knowledge pertaining to SARS-CoV-2 virology that includes in vitro and in vivo models for testing of antiviral therapies and randomized clinical trials.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new viral disease that has gained global attention owing to its ability to provoke community and health-care-associated outbreaks of severe infections in human populations.", "title_summ": "Current and future therapeutical approaches for COVID-19SARS-CoV-2 entry in host cells-multiple targets for treatment and preventionIn vitro and Animal Models for SARS-CoV-2 researchPreventing SARS-CoV-2 infection by blocking a tissue serine proteaseMonoclonal Antibody as a Potential Anti-COVID-19Potential applications of plant biotechnology against SARS-CoV-2Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions.", "title_abstract_phrases": "Potential applications of plant biotechnology against SARS-CoV-2Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for an ongoing human pandemic (COVID-19).Preventing SARS-CoV-2 infection by blocking a tissue serine proteaseCurrently, there are no proven pharmacologic interventions to reduce the clinical impact and prevent complications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the cause of the ongoing Coronavirus Disease of 2019 (COVID-19) pandemic.We also discuss potential therapeutic targets, either host virus based, that could be used to tackle the COVID-19 outbreak.In the present narrative, we review SARS-CoV-2 virology, clinical features, pathophysiology, and animal models with a specific focus on the antiviral and adjunctive therapies currently being tested or that require testing in animal models and randomized clinical trials.In vitro and Animal Models for SARS-CoV-2 researchAbstract Basic research on SARS-CoV-2 is essential to understand its detailed pathophysiology and identify best drug targets."}